IP & licensing
Evaluate and license patented encapsulation technology for ingredients that are difficult to formulate, stabilise or deliver.
BioGntx helps food, cosmetic and wellness companies test whether encapsulation can improve product performance before moving into licensing, co-development or commercialisation.
01. What you can license
Patent-protected formulation technology, ready to license.
BioGntx has developed patent-protected formulation technology for creating aqueous nanoparticle compositions containing lipophilic or poorly water-soluble compounds. The technology may support the development of differentiated products where solubility, dispersion, stability, or aqueous delivery format are important formulation challenges.
Patent overview
BioGntx's intellectual property includes a patent family relating to aqueous nanoparticle compositions comprising hydrophobic or lipophilic compounds.
- Patent / publication references
- NL2035231B1 and WO2025005799A1
- Applicant
- BioGntx R&D B.V.
- Status
- Granted in the Netherlands; international patent family status to be confirmed by jurisdiction.
The patent family broadly relates to methods and compositions for producing aqueous nanoparticle systems containing hydrophobic or lipophilic compounds using selected oil phases, emulsifier systems, processing steps, and particle-size control.
02. How it works
A clear, step-by-step path from idea to license.
Every engagement starts small, scales only with validated data and ends in a structured commercial route.
01
Initial screening call
Understand your ingredient, intended application and the formulation problem you want to solve.
02
Feasibility assessment
Evaluate technical and commercial potential before committing to prototype development.
03
Prototype development
Test real formulations using BioGntx's NLC-based encapsulation at R&D scale.
04
Option-to-license
A time-limited agreement defining scope, territory and commercial terms.
03. Challenge & opportunity
Turning formulation challenges into product solutions.
Many ingredients have strong commercial potential but are difficult to formulate. BioGntx helps companies explore whether encapsulation can turn those challenges into viable product solutions.
The challenge
Why high-value ingredients fail.
Ingredients don't mix well with water.
Active compounds degrade, oxidise or lose effectiveness over time.
Taste, smell or texture become difficult to control.
Products are hard to optimise, scale or deliver consistently.
The opportunity
What changes with the right approach.
More evenly dispersed within the formulation matrix.
Better protected, more stable over time.
Improved performance and a more consistent user experience.
A clear path toward IP licensing and commercial application.
Inside the platform
Encapsulation built around the molecules that matter.
04. Licensing opportunities
Flexible licensing and partnership structures.
BioGntx may consider licensing and partnership structures based on the specific active ingredient, product format, field of use, geography, exclusivity, development stage, and commercial channel.
Potential collaboration models may include
- 01
Feasibility assessment
- 02
Prototype development
- 03
Ingredient-specific licensing
- 04
Product-format-specific licensing
- 05
Field-of-use licensing
- 06
Geographic licensing
- 07
Exclusive or non-exclusive commercial rights, subject to agreement
- 08
Technical collaboration or transfer support where specifically agreed
Scope of license
Each license is defined by written agreement. Unless expressly agreed, a license does not automatically include manufacturing rights, exclusivity, BioGntx background know-how, trademarks, regulatory approvals, clinical or efficacy claims, sublicensing rights, or rights outside the agreed scope.